The retailer said in its newly released sustainability report that it’s “evolving” certain goals as it continues to try to ...
The emergence of advanced therapy medicinal products (ATMPs) including cell therapies, has led to many bioanalytical ...
Norovirus care results in about $28M in yearly costs for Veterans Health Administration, study finds
Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...
The company launched new products with biobased content, increased PCR content and strengthened recycling systems in 2024.
She received morphed obscene photographs of herself via WhatsApp and Telegram, created using her display picture. | Latest ...
Digital PCR (dPCR) is an excellent tool for rare target analysis applications because, unlike traditional PCR methods, dPCR divides samples into thousands of individual microreactions, then ...
GCR has introduced CICLICNXT, a new line of high-performance post-consumer recycled (PCR) polyolefins. In terms of potential ...
Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 ...
Peer through the window of one of Shane Pitt's pack of potent Mopars, and the dash plaque might say, "Built To Have Fun and ...
Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those ...
Influenza vaccination provided moderate protection against infection among UK health care workers during the 2023 to 2024 season.
European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott , an EU document shows, as global production of the tests is stretched by a surge in infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback